Skip to content

Algeldrate

ALIMENTARY TRACT AND METABOLISM

Also known as: aluminium hydroxide, aluminum hydroxide, aluminum hydroxide hydrate

FDA approvedATC A02AB01ATC A02AB02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Algeldrate is a drug catalogued in DrugCentral. It was first approved by the FDA in 1983. Recorded indications include Duodenal ulcer disease, Gastric Hypersecretory Conditions, Gastric ulcer and Gastroesophageal reflux disease.

  • Indications: Duodenal ulcer disease, Gastric Hypersecretory Conditions, Gastric ulcer, Gastroesophageal reflux disease and Heartburn and others.
  • ATC code: A02AB01 (Aluminium compounds).
  • Molecular formula: AlH3O3; molecular weight 78.00 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (7)

  • Duodenal ulcer disease
  • Gastric Hypersecretory Conditions
  • Gastric ulcer
  • Gastroesophageal reflux disease
  • Heartburn
  • Indigestion
  • Peptic ulcer

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1983-12-09FDA—SANOFI AVENTIS US

ATC classification

ATC codeTherapeutic hierarchy
A02AB01ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › ANTACIDS › Aluminium compounds
A02AB02ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › ANTACIDS › Aluminium compounds

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Schizoaffective disorder709.1
Drug level increased398.4
Electrocardiogram QT prolonged318.3
Drug interaction151.6
Sinus rhythm118.8
Appendicolith108.6
Hyperphosphataemia101.8
Myasthenia gravis91.5
Blood phosphorus increased88.2
Appendicitis85.8
Blood uric acid increased82.1
Ventricular fibrillation76.7

Chemical structure

Molecular formulaAlH3O3
Molecular weight78.00 g/mol
CAS number21645-51-2
InChIKeyWNROFYMDJYEPJX-UHFFFAOYSA-K
PubChem CID22721319
O[Al](O)O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Algeldrate used for?

DrugCentral lists the following indications for Algeldrate: Duodenal ulcer disease, Gastric Hypersecretory Conditions, Gastric ulcer, Gastroesophageal reflux disease, Heartburn, Indigestion and Peptic ulcer.

When was Algeldrate first approved?

Algeldrate was first approved by the FDA in 1983.

What is the chemical formula of Algeldrate?

Algeldrate has the molecular formula AlH3O3 and a molecular weight of 78.00 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1983-12-09
AgencyFDA
Targets0
Indications7
FormulaAlH3O3
DrugCentral ID4250
Interactive profile